Literature DB >> 34351485

[Frailty in renal diseases].

Lena Schulte-Kemna1, Miriam Künzig2, Dhayana Dallmeier3,4, Michael Denkinger3, René van Erp2, Martin Kächele2, Jochen Klaus5, Bernd Schröppel2.   

Abstract

The term frailty describes a complex syndrome of reduced resistance to stress factors as a consequence of age-related degeneration in various organ systems.In the general population frailty is associated with poor clinical outcomes, including an increased risk of falls, hospitalization, functional impairment and mortality. Frailty occurs earlier and its prevalence is higher in patients with chronic kidney disease (CKD) compared to the general population. Frail patients with CKD, on dialysis or not, have reduced quality of life and increased hospitalization and mortality rates, regardless of age, sex or comorbidities.The identification of frailty in patients with CKD can lead to the detection of important and potentially modifiable risk factors. Early nephrological evaluation coupled with an interdisciplinary approach including primary care physicians, geriatricians, physiotherapists, occupational therapists and nutritionists, is fundamental in the prevention of frailty as well as in the management of frail patients with CKD.Several instruments have been developed to screen for and assess the degree of frailty; however, there is currently no recommendation as to which should be used in nephrology and how to manage frail patients with CKD. In this article we suggest an approach based on a multidimensional, interdisciplinary evaluation aimed at the early identification and management of frail CKD patients independent of the clinical setting of admission; however, more important than the method used is the need to identify and follow-up on frail CKD patients.
© 2021. The Author(s).

Entities:  

Keywords:  Dialysis; Frailty; Geriatric medicine; Infirmity; Kidney

Year:  2021        PMID: 34351485     DOI: 10.1007/s00391-021-01953-0

Source DB:  PubMed          Journal:  Z Gerontol Geriatr        ISSN: 0948-6704            Impact factor:   1.281


  38 in total

1.  Frailty defined by deficit accumulation and geriatric medicine defined by frailty.

Authors:  Kenneth Rockwood; Arnold Mitnitski
Journal:  Clin Geriatr Med       Date:  2011-02       Impact factor: 3.076

2.  Significance of frailty among dialysis patients.

Authors:  Kirsten L Johansen; Glenn M Chertow; Chengshi Jin; Nancy G Kutner
Journal:  J Am Soc Nephrol       Date:  2007-10-17       Impact factor: 10.121

Review 3.  Frailty and chronic kidney disease: A systematic review.

Authors:  Rakin Chowdhury; Nancye M Peel; Mitchell Krosch; Ruth E Hubbard
Journal:  Arch Gerontol Geriatr       Date:  2016-10-22       Impact factor: 3.250

4.  Frailty, a multisystem ageing syndrome.

Authors:  Janani Thillainadesan; Ian A Scott; David G Le Couteur
Journal:  Age Ageing       Date:  2020-08-24       Impact factor: 10.668

Review 5.  Frailty, disability and physical exercise in the aging process and in chronic kidney disease.

Authors:  Antonio Greco; Giulia Paroni; Davide Seripa; Filomena Addante; Mariangela P Dagostino; Filippo Aucella
Journal:  Kidney Blood Press Res       Date:  2014-07-29       Impact factor: 2.687

6.  Frailty in older adults: evidence for a phenotype.

Authors:  L P Fried; C M Tangen; J Walston; A B Newman; C Hirsch; J Gottdiener; T Seeman; R Tracy; W J Kop; G Burke; M A McBurnie
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2001-03       Impact factor: 6.053

7.  A mitochondrial root to accelerated ageing and frailty.

Authors:  Luigi Ferrucci; Marta Zampino
Journal:  Nat Rev Endocrinol       Date:  2020-03       Impact factor: 43.330

8.  Influence of geographical factors in the distribution of pathogenic zymodemes of Entamoeba histolytica: identification of zymodeme XIV in India.

Authors:  P G Sargeaunt; U K Baveja; R Nanda; B S Anand
Journal:  Trans R Soc Trop Med Hyg       Date:  1984       Impact factor: 2.184

Review 9.  An overview of frailty in kidney transplantation: measurement, management and future considerations.

Authors:  Meera N Harhay; Maya K Rao; Kenneth J Woodside; Kirsten L Johansen; Krista L Lentine; Stefan G Tullius; Ronald F Parsons; Tarek Alhamad; Joseph Berger; XingXing S Cheng; Jaqueline Lappin; Raymond Lynch; Sandesh Parajuli; Jane C Tan; Dorry L Segev; Bruce Kaplan; Jon Kobashigawa; Darshana M Dadhania; Mara A McAdams-DeMarco
Journal:  Nephrol Dial Transplant       Date:  2020-07-01       Impact factor: 5.992

10.  Clinical Practice Guideline on management of older patients with chronic kidney disease stage 3b or higher (eGFR <45 mL/min/1.73 m2).

Authors:  Ken Farrington; Adrian Covic; Fillipo Aucella; Naomi Clyne; Leen de Vos; Andrew Findlay; Denis Fouque; Tomasz Grodzicki; Osasuyi Iyasere; Kitty J Jager; Hanneke Joosten; Juan Florencio Macias; Andrew Mooney; Dorothea Nitsch; Marijke Stryckers; Maarten Taal; James Tattersall; Dieneke Van Asselt; Nele Van den Noortgate; Ionut Nistor; Wim Van Biesen
Journal:  Nephrol Dial Transplant       Date:  2016-11       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.